BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 33611647)

  • 41. Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients.
    González Mazón I; Rueda-Gotor J; Ferraz-Amaro I; Genre F; Corrales A; Calvo Rio V; Palmou Fontana N; Portilla V; Llorca J; Mata C; Hernández-Hernández V; Quevedo-Abeledo JC; Rodríguez-Lozano C; Lopez Medina C; Ladehesa-Pineda ML; Castañeda S; Vicente EF; Fernández-Carballido C; Martínez-Vidal MP; Castro-Corredor D; Anino-Fernández J; Peiteado D; Plasencia-Rodríguez C; García-Vivar ML; Galíndez-Agirregoikoa E; Montes Perez E; Fernández Díaz C; Blanco R; González-Gay MA
    Semin Arthritis Rheum; 2021 Apr; 51(2):395-403. PubMed ID: 33607385
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fatigue in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Analysis from a Longitudinal Observation Cohort.
    Bedaiwi M; Sari I; Thavaneswaran A; Ayearst R; Haroon N; Inman RD
    J Rheumatol; 2015 Dec; 42(12):2354-60. PubMed ID: 26523020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation.
    Corbett M; Soares M; Jhuti G; Rice S; Spackman E; Sideris E; Moe-Byrne T; Fox D; Marzo-Ortega H; Kay L; Woolacott N; Palmer S
    Health Technol Assess; 2016 Feb; 20(9):1-334, v-vi. PubMed ID: 26847392
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the ASAS Health Index in patients classified as radiographic axial spondyloarthritis (axSpA) or non-radiographic axSpA in the ASAS Health Index international validation study.
    Fong W; Woon TH; Kwan YH; Braun J; van der Heijde D; Boonen A; Kiltz U
    RMD Open; 2024 Jan; 10(1):. PubMed ID: 38296803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis.
    Baraliakos X; Kiltz U; Peters S; Appel H; Dybowski F; Igelmann M; Kalthoff L; Krause D; Menne HJ; Saracbasi-Zender E; Schmitz-Bortz E; Vigneswaran M; Braun J
    Rheumatology (Oxford); 2017 Jan; 56(1):95-102. PubMed ID: 27997346
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Axial Spondyloarthritis in Japan.
    Kameda H; Kishimoto M; Kobayashi S; Tomita T; Morita A; Yamamura M
    Curr Rheumatol Rep; 2022 May; 24(5):149-155. PubMed ID: 35380380
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Burden of illness associated with non-radiographic axial spondyloarthritis: a multiperspective European cross-sectional observational study.
    Sieper J; Holbrook T; Black CM; Wood R; Hu X; Kachroo S
    Clin Exp Rheumatol; 2016; 34(6):975-983. PubMed ID: 27749215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices.
    Kleinert S; Schuch F; Rapp P; Ronneberger M; Wendler J; Sternad P; Popp F; Bartz-Bazzanella P; von der Decken C; Karberg K; Gauler G; Wurth P; Späthling-Mestekemper S; Kuhn C; Vorbrüggen W; Welcker M
    Rheumatol Int; 2024 Apr; 44(4):653-661. PubMed ID: 37805981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Content validity of the ASQoL for use in a non-radiographic axial spondyloarthritis population: a qualitative study.
    Hwang MC; Martin M; Harris K; Geerdts P; Stark JL; Reveille J
    Qual Life Res; 2020 Nov; 29(11):3155-3166. PubMed ID: 32607793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
    Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M
    Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Demographic and clinical differences between ankylosing spondylitis and non-radiographic axial spondyloarthritis: results from a multicentre retrospective study in the Lazio region of Italy.
    Chimenti MS; Conigliaro P; Navarini L; Martina FM; Peluso G; Birra D; Sessa P; Anzidei M; Scolieri P; Bruzzese V; Santoboni G; Cardello P; Gremese E; Afeltra A; Valesini G; Sebastiani GD; Perricone R; Scrivo R
    Clin Exp Rheumatol; 2020; 38(1):88-93. PubMed ID: 31140397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease: A narrative review.
    Magrey M; Schwartzman S; de Peyrecave N; Sloan VS; Stark JL
    Medicine (Baltimore); 2022 Apr; 101(15):e29063. PubMed ID: 35475794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Establishment of the current classification criteria for axial spondylarthritis, rheumatoid arthritis and SLE in routine practice of German rheumatologists].
    Schlieker R; Keyßer G
    Z Rheumatol; 2019 Dec; 78(10):979-986. PubMed ID: 31346705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does a short course of etanercept influence disease progression and radiographic changes in patients suspected of non-radiographic axial spondyloarthritis? Three -years follow- up of a placebo-controlled trial.
    Rusman T; van der Weijden M; Nurmohamed MT; van Denderen CJ; Landewé R; Bet PM; Bijl CV; van der Laken CJ; van der Horst-Bruinsma IE
    Scand J Rheumatol; 2023 Mar; 52(2):137-141. PubMed ID: 35543102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors of Assessment of Spondyloarthritis International Society (ASAS) Health Index in Axial Spondyloarthritis and Comparison of ASAS Health Index between Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Data from the Catholic Axial Spondyloarthritis COhort (CASCO).
    Min HK; Lee J; Ju JH; Park SH; Kwok SK
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30959846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Certolizumab pegol for treating axial spondyloarthritis.
    Desmarais J; Beier S; Deodhar A
    Expert Opin Biol Ther; 2016 Aug; 16(8):1059-64. PubMed ID: 27366922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical significance of possible HLA biomarkers in axial spondyloarthritis beyond HLA-B27 positivity.
    Šegota A; Schnurrer-Luke-Vrbanić T; Avancini-Dobrović V; Mirić F
    Rheumatol Int; 2023 Nov; 43(11):2073-2079. PubMed ID: 37450032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study.
    D'Angelo S; Malavolta N; Scambi C; Salvarani C; Caso F; Tirri E; Ramonda R; Quarta L; Erre GL; Riva M; Buono R; Furini F; Grembiale RD; Lomater C; Cantini F; Maio T; Chimenti MS; Scrivo R; Salaffi F; Caporali RF; Volpe P; Gualberti G; Marando F; Marchesoni A
    Clin Exp Rheumatol; 2021; 39(5):961-969. PubMed ID: 33427620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice.
    Wallman JK; Kapetanovic MC; Petersson IF; Geborek P; Kristensen LE
    Arthritis Res Ther; 2015 Dec; 17():378. PubMed ID: 26703005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA).
    Robinson PC; Bird P; Lim I; Saad N; Schachna L; Taylor AL; Whittle SL; Brown MA
    Int J Rheum Dis; 2014 Jun; 17(5):548-56. PubMed ID: 24673897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.